Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?

Endri Mauro, P. Passadore, L. Quartuccio, S. De Vita, A. Ermacora, V. Gattei, C. Mazzaro

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)672-673
Number of pages2
JournalActa Gastro-Enterologica Belgica
Issue number4
Publication statusPublished - Oct 1 2020

ASJC Scopus subject areas

  • Gastroenterology

Cite this